Navigation Links
Notice Begins Announcing Pendency of a Class Action Regarding MetLife
Date:7/21/2009

NEW YORK, July 21 /PRNewswire/ -- The notice process has begun in a pending class action against MetLife. The class action involves MetLife's April 2000 conversion from a mutual insurance company to a stock company. The nationwide class action certified by the Federal Court in New York includes more than 8.6 million current and former MetLife policyholders.

The notice of the class action will be mailed to more than 5 million current and former policyholders. The notice will also be published in two national newspapers. A more detailed notice is available at www.insuranceclassaction.net. Additional information is also at 800-961-8147.

The text of the mailed notice is set out below.

    ------------------------------------------------------------
    United States District Court
    Eastern District of New York

    In Re MetLife Demutualization Litigation
    00cv2258 (TCP) (AKT)

NOTICE OF CLASS ACTION

METROPOLITAN LIFE INSURANCE COMPANY ("MetLife Co.") POLICYHOLDERS WHO RECEIVED IN METLIFE CO.'S DEMUTUALIZATION AT LEAST (a) 11 TRUST INTERESTS OR (b) $156.75 IN CASH OR POLICY CREDITS.

YOU MAY BE A CLASS MEMBER IN THIS LAWSUIT AND YOUR RIGHTS COULD BE AFFECTED.

This notice describes (1) this class action lawsuit; (2) the class definition; (3) your right to share in any judgment or settlement, and the binding effect on you of any judgment or settlement if you do not exclude yourself from the class; (4) your right to be excluded from the class and how to exclude yourself; and (5) how to get more information.

This Lawsuit In April 2000, Metropolitan Life Insurance Company ("MetLife Co.") converted from a mutual insurance company to a stock company, called "demutualization." The suit is against MetLife Co. and MetLife, Inc. ("Defendants") by policyholders in the demutualization ("Plaintiffs"). Plaintiffs allege Defendants sent policyholders an information package that omitted material facts and contained false statements, to win the policyholders' vote to demutualize. Plaintiffs allege Defendants violated certain federal securities laws and damaged class members. Defendants deny plaintiffs' claims and are contesting the suit. Defendants believe they did not omit material information or make false statements to policyholders, and that class members were not damaged.

Class Members You received this notice because you may be a class member. In a class action, claims common to a group, called class members, are litigated together. The results bind all class members. Class members' rights will be affected by this lawsuit.

You are a class member if you received in MetLife Co.'s demutualization (a) 11 or more trust interests in MetLife, Inc. stock or (b) cash payment or policy credits of $156.75 or more.

Remaining a class member If you are a class member and do not exclude yourself (as described below), you will remain a class member. You will be represented by Lead Plaintiffs and Lead Counsel, Jared Stamell, Esq. You will share in any judgment and be bound by the Court's decisions, whether favorable or unfavorable. You will not be personally liable for attorneys' fees or other expenses. You may not bring your own suit for the same claims. (If you wish, you may be represented in this class action by your attorney at your own expense.)

Excluding yourself You can exclude yourself from the class. If you exclude yourself, you will not share in any judgment in the case or be bound by the Court's decisions, and may pursue your own claim against Defendants individually, at your own expense.

TO EXCLUDE YOURSELF, YOU MUST MAIL BY September 8, 2009 a signed, dated statement (with your name, the policy owner's name (if different from your name), policy number, your address and telephone number) saying you exclude yourself from the MetLife Demutualization Litigation to: MetLife Demutualization Litigation, Notice Administrator, c/o Gilardi & Co LLC, P.O. Box 808054, Petaluma, CA 94975-8054

More Information This notice does not describe all the lawsuit's details. All papers filed in this case can be inspected at: Clerk, U.S. District Court, 100 Federal Plaza, Central Islip, NY 11722. Additional information, including a more detailed notice, is at: WWW.INSURANCECLASSACTION.NET

DO NOT ADDRESS QUESTIONS TO THE CLERK OF THE COURT OR THE JUDGE.

DO NOT CALL METLIFE OR YOUR AGENT ABOUT THIS NOTICE OR THE CASE.

FOR QUESTIONS VISIT WWW.INSURANCECLASSACTION.NET OR CALL 800-961-8147.

    ------------------------------------------------------------
    CONTACT:  STAMELL & SCHAGER
              JARED B. STAMELL, 212-566-4047


'/>"/>
SOURCE Law firm of Stamell & Schager, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
2. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
3. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
4. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. Medifast Receives Notice Regarding NYSE Listing
7. Melanomas may appear noticeably different than other moles
8. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
9. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
10. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
11. Politics has taken notice of science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
(Date:12/8/2016)... Payne, AL (PRWEB) , ... December 08, 2016 ... ... offering insurance and financial consulting services to residential and commercial clients in the ... awareness and support for Nobis Works. , Since 1977, Nobis Works has built ...
(Date:12/7/2016)... VA (PRWEB) , ... December 07, 2016 , ... ... are celebrating the passage of the most comprehensive mental health systems reform legislation ... the support of the President, and the commitment of our elected officials to ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Haemonetics Corporation (NYSE: HAE ) has ... an innovative software suite designed to help customers drive efficiency ... of NextGen DMS 4 improves core features and introduces innovations ... liter of plasma collected, enhancing quality and regulatory compliance and ... ...
(Date:12/8/2016)... SINGAPORE , BEIJING , and ... a leading commercial provider of genomic services and solutions with ... a Singapore biotechnology company; and the ... today that NovogeneAIT Genomics Singapore (NovogeneAIT) – a new joint ... whole genome sequencing (WGS) centre at Biopolis, Singapore ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: